急性A型主动脉夹层伴灌注不良综合征:先腔内开窗/支架再延期开放修复
该单中心回顾性研究纳入1996至2017年597例急性A型主动脉夹层患者,其中135例合并灌注不良综合征(MPS)者接受先行腔内再灌注(开窗/支架)后延期开放修复(OR)。两个十年间院内死亡率从21.0%降至10.7%(P<0.001);第二十年间,MPS患者因主动脉破裂死亡从16%降至4%(P=0.05),器官衰竭死亡风险是破裂死亡的6.63倍(95%CI 1.5-29;P=0.01),OR后30天死亡率为3.7%。与文献模型预测的“全员即刻OR”预期死亡率相比,实际30天和院内死亡率(9%和11%)显著更低(P≤0.03)。
要点
- 对相对稳定(无破裂、无心包填塞)的MPS患者,先行腔内再灌注后延期OR的分阶段策略可能获益。
- 第二十年间MPS患者因主动脉破裂死亡降至4%,OR后30天死亡率为3.7%。
- 器官衰竭死亡风险是主动脉破裂死亡的6.63倍(95%CI 1.5-29;P=0.01)。
核心结论
- 对多数急性A型主动脉夹层患者,即刻开放修复仍是预防主动脉破裂死亡的首选策略。
- 对相对稳定(无破裂、无心包填塞)的MPS患者,先行腔内再灌注后待器官衰竭缓解再行主动脉开放修复的分阶段策略可获益。
研究设计与样本
- 单中心回顾性研究,1996至2017年共纳入597例急性A型主动脉夹层患者,其中135例合并MPS并接受先行腔内再灌注(开窗/支架)后延期开放修复。
- 比较第一个十年与第二个十年的结局,并用文献中的预后模型(Verona、Leipzig-Halifax、Stockholm、Penn和GERAADA模型)估算“全员即刻开放修复”的预期死亡率进行对照。
主要发现
- 总体院内死亡率在两个十年间改善(21.0% vs 10.7%,P<0.001)。
- 第二个十年中,初始接受开窗/支架治疗的MPS患者因主动脉破裂死亡从16%降至4%(P=0.05)。
- 第二个十年中,MPS患者因器官衰竭死亡的风险是主动脉破裂死亡的6.63倍(HR=6.63;95%CI 1.5-29;P=0.01)。
- 第二个十年中,MPS患者开放修复后30天死亡率为3.7%。
- 与“全员即刻开放修复”模型预期死亡率相比,全部急性A型主动脉夹层患者实际30天和院内死亡率(9%和11%)显著更低(P≤0.03)。
临床怎么用
- 对合并MPS的急性A型主动脉夹层患者,应先评估是否相对稳定(无破裂、无心包填塞)。
- 对相对稳定者,可考虑先行腔内再灌注(开窗/支架),待器官衰竭缓解后再延期行主动脉开放修复。
局限性
- 本研究为单中心回顾性研究,证据等级有限。
- 与文献预后模型的预期死亡率比较并非随机对照,可能存在选择偏倚和时代效应混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immediate open repair of acute type A aortic dissection is traditionally recommended to prevent death from aortic rupture. However, organ failure because of malperfusion syndrome (MPS) might be the most imminent life-threatening problem for a subset of patients. METHODS: From 1996 to 2017, among 597 patients with acute type A aortic dissection, 135 patients with MPS were treated with upfront endovascular reperfusion (fenestration/stenting) followed by delayed open repair (OR). We compared outcomes between the first and second decades and observed mortalities with those expected with an "upfront OR for every patient" approach, determined using prognostic models from the literature (Verona, Leipzig-Halifax, Stockholm, Penn, and GERAADA [German Registry for Acute Aortic Dissection Type A] models). RESULTS: Overall, in-hospital mortality improved between the 2 decades (21.0% versus 10.7%, P<0.001). In the second decade, for patients with MPS initially treated with fenestration/stenting, mortality from aortic rupture decreased from 16% to 4% ( P=0.05), the risk of dying from organ failure was 6.6 times higher than dying from aortic rupture (hazard ratio=6.63; 95% CI, 1.5-29; P=0.01), and 30-day mortality after OR for MPS patients was 3.7%. Compared to the expected mortalities with the upfront OR for every patient models, our observed 30-day and in-hospital mortalities (9% and 11%, respectively) of all patients with acute type A aortic dissection were significantly lower ( P≤0.03). CONCLUSIONS: Immediate OR is the strategy to prevent death from aortic rupture for the majority of patients with acute type A aortic dissection. However, relatively stable (no rupture, no tamponade) patients with MPS benefit from a staged approach: upfront endovascular reperfusion followed by aortic OR at resolution of organ failure.
引用
- Yang B, Rosati CM, Norton EL, et al. Endovascular Fenestration/Stenting First Followed by Delayed Open Aortic Repair for Acute Type A Aortic Dissection With Malperfusion Syndrome. Circulation. 2018. PMID: 30474418. doi:10.1161/CIRCULATIONAHA.118.036328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。